Concepts (103)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Positron-Emission Tomography | 7 | 2022 | 293 | 1.070 |
Why?
|
| Withania | 1 | 2026 | 2 | 0.960 |
Why?
|
| Plant Extracts | 1 | 2026 | 127 | 0.860 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2026 | 341 | 0.720 |
Why?
|
| Fluorodeoxyglucose F18 | 3 | 2026 | 125 | 0.720 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2022 | 2107 | 0.660 |
Why?
|
| Positron Emission Tomography Computed Tomography | 2 | 2026 | 80 | 0.650 |
Why?
|
| Multimodal Imaging | 4 | 2022 | 109 | 0.630 |
Why?
|
| Embolization, Therapeutic | 1 | 2022 | 231 | 0.610 |
Why?
|
| Lung Neoplasms | 1 | 2026 | 1543 | 0.470 |
Why?
|
| Polycystic Kidney, Autosomal Dominant | 1 | 2015 | 13 | 0.450 |
Why?
|
| Pyelonephritis | 1 | 2015 | 28 | 0.450 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2015 | 95 | 0.450 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2016 | 265 | 0.440 |
Why?
|
| Hydranencephaly | 1 | 2014 | 1 | 0.440 |
Why?
|
| Carcinoma, Acinar Cell | 1 | 2014 | 7 | 0.440 |
Why?
|
| Parotid Neoplasms | 1 | 2014 | 20 | 0.430 |
Why?
|
| Cysts | 1 | 2015 | 88 | 0.430 |
Why?
|
| Parathyroid Neoplasms | 1 | 2014 | 22 | 0.420 |
Why?
|
| Meningeal Neoplasms | 1 | 2014 | 220 | 0.360 |
Why?
|
| Liver Neoplasms | 1 | 2022 | 1395 | 0.350 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2014 | 282 | 0.340 |
Why?
|
| Glioma | 1 | 2016 | 522 | 0.340 |
Why?
|
| Urinary Tract Infections | 1 | 2015 | 328 | 0.330 |
Why?
|
| Radiopharmaceuticals | 5 | 2015 | 163 | 0.260 |
Why?
|
| Adenocarcinoma | 1 | 2014 | 986 | 0.260 |
Why?
|
| Brain Neoplasms | 1 | 2016 | 1344 | 0.240 |
Why?
|
| Plant Leaves | 1 | 2026 | 53 | 0.230 |
Why?
|
| Yttrium | 1 | 2022 | 5 | 0.190 |
Why?
|
| Microspheres | 1 | 2022 | 67 | 0.190 |
Why?
|
| Yttrium Radioisotopes | 1 | 2022 | 27 | 0.190 |
Why?
|
| Radiometry | 1 | 2022 | 52 | 0.180 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2021 | 67 | 0.160 |
Why?
|
| Neuroendocrine Tumors | 1 | 2021 | 69 | 0.160 |
Why?
|
| Female | 10 | 2026 | 70285 | 0.150 |
Why?
|
| Biomarkers, Tumor | 1 | 2026 | 1606 | 0.130 |
Why?
|
| Humans | 14 | 2026 | 130422 | 0.120 |
Why?
|
| Middle Aged | 5 | 2026 | 28383 | 0.120 |
Why?
|
| Indium Radioisotopes | 1 | 2015 | 7 | 0.120 |
Why?
|
| Adult | 5 | 2026 | 31127 | 0.110 |
Why?
|
| Neoplasm Grading | 1 | 2016 | 277 | 0.110 |
Why?
|
| Sensitivity and Specificity | 3 | 2016 | 2106 | 0.110 |
Why?
|
| Lung | 1 | 2022 | 1547 | 0.110 |
Why?
|
| Male | 6 | 2026 | 64527 | 0.100 |
Why?
|
| Body Burden | 1 | 2011 | 4 | 0.090 |
Why?
|
| Fluorine Radioisotopes | 1 | 2011 | 11 | 0.090 |
Why?
|
| Whole-Body Counting | 1 | 2011 | 6 | 0.090 |
Why?
|
| Integrin alphaVbeta3 | 1 | 2011 | 16 | 0.090 |
Why?
|
| Oligopeptides | 1 | 2011 | 105 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2022 | 3815 | 0.080 |
Why?
|
| Rubidium Radioisotopes | 1 | 2009 | 3 | 0.080 |
Why?
|
| Coronary Circulation | 2 | 2009 | 187 | 0.080 |
Why?
|
| Perfusion Imaging | 1 | 2009 | 12 | 0.080 |
Why?
|
| Ammonia | 1 | 2009 | 68 | 0.070 |
Why?
|
| Technetium Tc 99m Sestamibi | 1 | 2009 | 24 | 0.070 |
Why?
|
| Heart Rate | 2 | 2009 | 574 | 0.070 |
Why?
|
| Aged | 2 | 2026 | 20894 | 0.070 |
Why?
|
| Adenosine | 1 | 2009 | 118 | 0.070 |
Why?
|
| Exercise Test | 1 | 2009 | 234 | 0.070 |
Why?
|
| Blood Flow Velocity | 1 | 2009 | 418 | 0.070 |
Why?
|
| Coronary Artery Disease | 2 | 2009 | 891 | 0.060 |
Why?
|
| Friedreich Ataxia | 1 | 2007 | 30 | 0.060 |
Why?
|
| Myocardial Ischemia | 1 | 2009 | 308 | 0.060 |
Why?
|
| Oxygen Consumption | 1 | 2007 | 298 | 0.060 |
Why?
|
| Retrospective Studies | 1 | 2022 | 17614 | 0.050 |
Why?
|
| Heart | 1 | 2007 | 661 | 0.050 |
Why?
|
| Cardiomyopathies | 1 | 2007 | 515 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2022 | 597 | 0.040 |
Why?
|
| Medical Oncology | 1 | 2021 | 240 | 0.040 |
Why?
|
| Coronary Vessels | 2 | 2007 | 523 | 0.030 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 1996 | 37 | 0.030 |
Why?
|
| Adolescent | 1 | 2014 | 20754 | 0.030 |
Why?
|
| Algorithms | 1 | 2022 | 1680 | 0.030 |
Why?
|
| Actins | 1 | 1996 | 315 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 1996 | 1607 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2009 | 2919 | 0.020 |
Why?
|
| Metabolic Clearance Rate | 1 | 2011 | 132 | 0.020 |
Why?
|
| Radiation Dosage | 1 | 2011 | 136 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2011 | 364 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2011 | 397 | 0.020 |
Why?
|
| Heart Transplantation | 1 | 1996 | 824 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 2009 | 114 | 0.020 |
Why?
|
| Carbon Isotopes | 1 | 2009 | 228 | 0.020 |
Why?
|
| Arm | 1 | 2009 | 72 | 0.020 |
Why?
|
| Vasodilator Agents | 1 | 2009 | 198 | 0.020 |
Why?
|
| Electric Conductivity | 1 | 2007 | 80 | 0.020 |
Why?
|
| Body Size | 1 | 2007 | 58 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2011 | 1452 | 0.020 |
Why?
|
| Organ Size | 1 | 2007 | 419 | 0.010 |
Why?
|
| Myocardial Contraction | 1 | 2007 | 241 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2009 | 1498 | 0.010 |
Why?
|
| Survival Rate | 1 | 2009 | 2131 | 0.010 |
Why?
|
| Heart Ventricles | 1 | 2007 | 757 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2007 | 1337 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2009 | 3682 | 0.010 |
Why?
|
| Arterioles | 1 | 1996 | 38 | 0.010 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1996 | 226 | 0.010 |
Why?
|
| Risk Factors | 1 | 2009 | 10942 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 1996 | 451 | 0.010 |
Why?
|
| United States | 1 | 2009 | 11827 | 0.010 |
Why?
|
| Biopsy | 1 | 1996 | 1239 | 0.010 |
Why?
|
| Myocardium | 1 | 1996 | 859 | 0.010 |
Why?
|
| Prospective Studies | 1 | 1996 | 6423 | 0.000 |
Why?
|